NCT00612352View on ClinicalTrials.gov

Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alcoholism
Interventions
DRUG

Ethanol High Dose, Ethanol Low Dose, and Placebo

Three test days will involve administration of placebo, ethanol high dose (BrAc=100mg%) or ethanol low dose (BrAc=40mg%)intravenously for approximately 20 minutes, until the target BrAc is achieved. Once BrAc is achieved (40mg% or 100mg%) it will be maintained using a clamp procedure for 60 minutes.

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
collaborator

VA Connecticut Healthcare System

FED

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT00612352 - Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism | Biotech Hunter | Biotech Hunter